Julie A. Stone, PhD
Scientific Assoc. VP
Merck & Co., Inc.
West Point, Pennsylvania, United States
Disclosure(s): Merck & Co., Inc.: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Youfang Cao, PhD
Director of Pharmacometrics
Eisai, Inc
Nutley, New Jersey, United States
Disclosure(s): Eisai Inc: Employment (Ongoing)
Brian A. Willis, PhD (he/him/his)
Head of Pharmacometrics
Biogen, Indiana, United States
Disclosure(s): Biogen: Employment (Ongoing); Eisai Inc: Employment (Terminated); Eli Lilly: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Ivelina Gueorguieva, PhD (she/her/hers)
Sr Director, Global PK/PD and Pharmacometrics
Eli Lilly and Company, United Kingdom
Disclosure(s): Eli Lilly: Employment (Ongoing)
Stephen Duffull, PhD (he/him/his)
Senior Scientific Advisor
Certara, Otago, New Zealand
Disclosure(s): Certara: Employment (Ongoing)
